Multidrug-resistant tuberculosis: A review of the 23 cases treated by the saint-pierre university hospital (brussels)

Acta Clinica Belgica

Volumn 64, Issue 2, 2009, Pages 113-119

  Jacob, V ^a   Robert, L ^b   Lebrun, C ^b   Laethem, Y Van ^a   Sergysels, R ^a,b  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b The FARES (The Fund of Respiratory Affections)   (Belgium)

Author keywords

BELTA tbnet; Multidrug resistant tuberculosis; Respiratory isolation; Treatment

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; ASYLUM SEEKER; BELGIUM; CLINICAL ARTICLE; CLINICAL FEATURE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EYE COLOR; FOLLOW UP; HEADACHE; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLEGAL IMMIGRANT; LENGTH OF STAY; MISCELLANEOUS NAMED GROUPS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; OPTIC NEURITIS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN DISCOLORATION; TOXIC HEPATITIS; TREATMENT DURATION; UNIVERSITY HOSPITAL; URINE COLOR; VOMITING;

EID: 64949192112     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2009.020     Document Type: Article

References (19)

1. Schwoebel V, Lambregts-van Weezenbeek CSB, et al. Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working group. Eur Resp J 2000; 16: 364-71.
2. WHO. Anti-tuberculosis drug resistance in the world. Fourth global report. World Health Organization Document, 2008. WHO/HTM/TB/2008.394.
3. F.A.R.E.S. Registre beige de la tuberculose 2006. Data available on demand: maryse.wanlin@euronet.be.
4. WHO. Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization Document, 2006. WHO/HTM/TB/2006.361.
5. Blöndal K. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ. 2007; 85: 387-94.
6. Loïez-Durocher C, Vachee A, Lemaitre N. Drug resistance in Mycobacterium tuberculosis: diagnostic methods. Ann Biol Clin (Paris) 2000; 58:291-7.
7. Brodie D, Schluger NW.The diagnosis of Tuberculosis. Clin Chest Med2005; 26: 247-71.
8. La tuberculose a germes (multi)resistants F.A.R.E.S 2001. www.Fares.be.
9. Centers for Disease Control and Prevention, American Thoracic Society, Infectious Disease Society of America. Treatment of tuberculosis. Morbidity and Mortality Weekly Report 2003, 52(RR11):1-77.
10. Fedasil (Agence federate pour I'accueil des demandeurs d'asile). Rapport annuel 2006. www.Fedasil.be.
11. Ministere des Affaires Sociales, de la Sant6 Publique et de I'Environnement beige Recommandations pour la prevention de I'infection tuberculeuse dans les institutions de soins-avril 1996. www. md.acl.ac.be.
12. Centers for Disease Control and Prevention (CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morbidity and Mortality Weekly Report 1994,43(RR13): 1-132.
13. BELTA-TBnet. Coordinator Doctor Guido Groenen. www.betta.be.
14. Prévention et prise en charge de la tuberculose en France. Syntháse et recommandations du groupe de travail du Conseil Suṕrieur d'Hygiéne Publique de France(2002-2003). Rev Mai Respir 2003; 20: 7S1-7S106.
15. Fattorini L, Tan D, lona E,et at. Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c Mice. Antimicrob Agents Chemother 2003; 47:360-2.
16. Alcala L, Ruiz-Serrano MJ, PeYez-Fernandez Turegano C, et at. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother 2003; 47:416-7.
17. Tato M, de la Pedrosa EC, Canton R, et al. In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents 2006; 28: 75-8.
18. Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH. Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J CardiothoracSurg 1999; 16:187-93.
19. Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001; 121:448-53.